Clinical trials: Endoscopic Sleeve Gastroplasty
Non-alcoholic Steatohepatitis (NASH), Endoscopic Sleeve Gastroplasty
A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. Affecting approximately one-third of the United States (U.S.) population, the prevalence of NAFLD increases to 90% in patients with…
- Conditions
- Non-alcoholic Steatohepatitis (NASH), Endoscopic Sleeve Gastroplasty, Non-alcoholic Fatty Liver Disease (NAFLD), Endoscopic Ultrasound
- Trial name
- NCT04820036
- Testing
- Insulin Resistance, Quality of Life Assessment, Liver Function Test
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Brigham and Women's Hospital
Endoscopic Tissue Apposition, Endoscopic Suturing
Prospective Evaluation of the Efficacy and Safety of Endoscopic Tissue Apposition
This study is a prospective registry of patients undergoing endoscopic suturing and/or clip placement at our institution to assess the efficacy and safety of endoscopic tissue apposition.
- Conditions
- Endoscopic Tissue Apposition, Endoscopic Suturing, Endoscopic Clipping, Bariatric Endoscopy
- Trial name
- NCT03626194
- Where
- United States
- Volunteers
- 500 people
- Sponsor
- University of Colorado, Denver
Endoscopic Sleeve Gastroplasty, Obesity
Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity
The purpose of this study is to evaluate endoscopic sleeve gastroplasty (ESG) for the treatment of obesity. The ESG procedure is an U.S.
- Trial name
- NCT06339320
- Testing
- Endoscopic Sleeve Gastroplasty (ESG), Apollo OverStitch endoscopic suturing device
- Where
- 2 sites in United States
- Volunteers
- 150 people
- Sponsor
- The Methodist Hospital Research Institute
Obesity, Endoscopic Sleeve Gastroplasty
Endoscopic Sleeve Gastroplasty for Obesity and Microbiota Randomized Trial
This is an interventional, open-label, randomized (2:1), standard medical therapy-controlled trial. Subjects in the standard therapy group will be given the opportunity to undergo the active endoscopic treatment after 6 months of…
- Conditions
- Obesity, Endoscopic Sleeve Gastroplasty, Gastric Motility, Gastric Hormones
- Trial name
- ESGORT (NCT04200144)
- Testing
- Endoscopic sleeve gastroplasty
- Where
- Italy
- Volunteers
- 60 people
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Obesity, Morbid, End Stage Renal Disease
Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates
The aim of this pilot prospective interventional study is to evaluate the efficacy of endoscopic sleeve gastroplasty (ESG) in allowing obese subjects (≥35 kg/m2) with end stage renal disease who need of kidney transplantation to…
- Conditions
- Obesity, Morbid, End Stage Renal Disease, Kidney Transplantation, Endoscopic Sleeve Gastroplasty
- Trial name
- ESGiTXKidney (NCT05917795)
- Testing
- Endoscopic Sleeve Gastroplasty (ESG)
- Where
- Italy
- Volunteers
- 24 people
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Endoscopic Sleeve Gastroplasty, Laparoscopic Sleeve Gastrectomy
Hormonal and Metabolic Aspects of Endoscopic Sleeve Gastroplasty
The investigators of the study want to investigate the complex interactions between glucose metabolism, food intake/weight loss, and different appetite regulating hormones after ESG in comparison with conventional laparoscopic…
- Conditions
- Endoscopic Sleeve Gastroplasty, Laparoscopic Sleeve Gastrectomy, Gut Hormones, Glucose Metabolism Disorders
- Trial name
- NCT04452786
- Testing
- Endoscopic sleeve gastroplasty, Laparoscopic sleeve gastrectomy
- Where
- Denmark
- Sponsor
- Hvidovre University Hospital
Endoscopic Sleeve Gastroplasty, Laparoscopic Sleeve Gastrectomy
ESG vs LSG: Short-term Nutritional Outcomes
To assess endoscopic sleeve gastroplasty in comparison to laparoscopic sleeve gastrectomy before and 3 months after the procedure in terms of multiple nutrition-related factors, quality of life, weight and other related…
- Conditions
- Endoscopic Sleeve Gastroplasty, Laparoscopic Sleeve Gastrectomy, Obesity
- Trial name
- NCT04264364
- Testing
- Laparoscopic sleeve gastrectomy, Endoscopic sleeve gastroplasty
- Where
- Saudi Arabia
- Volunteers
- 57 people
- Sponsor
- King Saud University
Endoscopic Sleeve Gastroplasty
Endoscopic Sleeve Gastroplasty for Morbid Obesity
Obesity and its related metabolic disorders are increasingly a heavy health burden to many parts of the world. Weight control is a well-known important step in avoiding type 2 diabetes mellitus (T2DM).
- Trial name
- NCT03124485
- Testing
- Endoscopic Sleeve Gastroplasty, Laparoscopic Sleeve Gastrectomy
- Where
- China
- Volunteers
- 37 people
- Sponsor
- Chinese University of Hong Kong